GMAB
$39.07+1.48%
as of close, Oct 20, 2026
☾ AH $39.07 +1.48%
Genmab A/S ADSStock · Healthcare
GMAB — Genmab A/S ADS price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeSEEEEEEEEEEEE
15.020.025.030.035.040.045.0020.0M40.0M$39.07—20162019202120242026
2026-10-20
Price$39.07
MA20$30.97
MA50$30.05
Vol11.2M
Key stats#
Price data
- Price
- $39.07
- YTD price return
- +26.85%
- YTD total return
- +26.85%
- Next earnings
- Nov 5, 2026 · Before open
- Market cap
- 5B
- Enterprise value
- 8.3B
- Shares outstanding
- 128.5M
- 52W low
- $23.62
- 52W high
- $40.17
- From 52W high
- -2.74%
- From 52W low
- +65.41%
- 52W range
- 93%
Volume
- Rel volume
- 1.05×
- 30D volume
- 3.6M
- 30D $ vol
- 130.4M
Fundamentals
- Sales (ttm)
- 3.7B
- Sales/share
- $28.95
- EPS (ttm)
- $7.69
- FCF (ttm)
- 1.1B
- FCF/share
- $8.94
- Book value/share
- $45.51
- Net margin
- 25.89%
- ROE
- 16.47%
- ROA
- 7.48%
- Debt / equity
- 0.86×
- Current ratio
- 2.02
Growth (CAGR, ttm) · 10Y
- Shares
- -2.95%n/an/an/a
Per-share growth (CAGR, ttm) · 10Y
- Book value/share
- +17.29%n/an/an/a
- Price
- +27.95%+9.40%-3.15%+8.74%
- Total return
- +27.95%+9.40%-3.15%+8.74%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 5.1×
- P/OI (ttm)
- 4.7×
- Fwd P/E
- 24.1×
- P/S (ttm)
- 1.3×
- P/B (mrq)
- 0.9×
- P/FCF (ttm)
- 4.4×
- EV/EBITDA (fy)
- 7.8×
- EV/Sales (ttm)
- 2.2×
- FCF yield (ttm)
- 22.89%
- Buyback yield (realized, 1y)
- 2.95%
- Shareholder yield (realized, 1y)
- 2.95%
- Buyback yield (cash, ttm)
- 8.57%
- Shareholder yield (cash, ttm)
- 8.57%
Vs own 10Y history
- P/E
- 9th
- P/OI
- 9th
- P/S
- 9th
- P/B
- 20th
- P/FCF
- 9th
Bar = where today’s multiple sits in GMAB’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-20#
1D
+1.48%
5D
+6.84%
1M
+12.46%
3M
+39.99%
YTD
+26.85%
1Y
+27.93%
5Y
-14.77%
Recent filings#
No earnings release, press release or insider trade outside a 10b5-1 plan in the last 120 days.
All filings and insider trades →Financial statements
Open full GMAB financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +11.34% | +3.49% |
| JNJ | Johnson & Johnson | -3.94% | +2.19% |
| ABBV | AbbVie Inc. | +9.52% | +2.26% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +11.24% | +3.04% |
| MRK | Merck & Co. Inc. | +0.97% | +3.25% |
| NVS | Novartis AG | +9.45% | +2.29% |
| TMO | Thermo Fisher Scientific Inc. | +5.51% | +1.18% |
| AMGN | Amgen Inc. | +13.82% | +3.29% |
